NDAINHALATIONAEROSOL, METERED
Approved
Sep 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
5/8 — Partial
ATROPINE SULFATE (atropine sulfate) by Medica Corp is muscarine-like actions of acetyl-choline and is therefore classified as an antimuscarinic agent. Approved for myopia. First approved in 1990.
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Atropine sulfate is an antimuscarinic agent that blocks muscarinic acetylcholine receptors, indicated for myopia management. It works by inhibiting cholinergic activation of the pupillary sphincter and ciliary muscle, inducing mydriasis and cycloplegia. The inhalation aerosol formulation delivers the drug as a metered dose.
$0.017BPart D
LOE ApproachingDeclining
This NDA product faces significant LOE risk with limited Part D activity ($17K annually, 358 claims in 2023), signaling a contracting brand team and reduced career growth opportunities.
Mechanism of Action
muscarine-like actions of acetyl-choline and is therefore classified as an antimuscarinic agent. Atropine is relatively selective for muscarinic receptors. Its potency at nicotinic receptors is much lower, and actions at non-muscarinic receptors are generally undetectable clinically. Atropine does…
Indications (1)
Clinical Trials (3)
A Study of Atropine Sulfate in Healthy Chinese Volunteers
Started May 2023
30 enrolled
Pharmacokinetics
A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
Started May 2022
526 enrolled
Myopia
A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
Started Mar 2022
777 enrolled
Myopia
Worked on ATROPINE SULFATE at Medica Corp? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.